Celldex Therapeutics Inc. (CLDX) Gained 5.17% or 0.02 To Price $0.45 On Tuesday


Celldex Therapeutics Inc. (CLDX) gained 5.17% or 0.02 to $0.45. It is about 1.07 million shares traded, which is 45.74% compare to the average total volume 2.34 million. The market cap of CLDX is $65.10 million. The year to date change is -80.05%. The 52 week price range is from $0.41 to $3.26. Price of CLDX have changed -7.16% during last week. It have changed -17.77% over last month, -44.87% over last 3 months, -82.45% over last 6 months and -82.52% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CLDX is 0.54. It is 20.00% above current price. The 200-day Moving Averages for CLDX is 1.85. It is 311.11% above current price. The 52-week High is 3.26. It is 624.44% from the current price. The 52-week Low is 0.41. It is -8.89% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of CLDX is 1.1 on 2018-07-13. Short % to float is 2.80%. There are some statistics of CLDX. It is has market cap $65.10 million. The share outstanding is 143.39 million. The average volume is 2.34 million. The revenue is 7.75M. The percent of top 15 Institution holding is 53.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CLDX is -84.06%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CLDX is -58.19%.


Tags:

Share this post